Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Targeted therapy cancer brands to achieve sales of over $42 billion by 2017
Pharmaceutical Business Review
Saturday, October 4, 2008 - 3:04pm
tags:
Bayer wins marketing approval for anticoagulant drug
Pharmaceutical Business Review
Saturday, October 4, 2008 - 3:03pm
tags:
Sanofi: Long-Term Generic Impact
Zacks
Saturday, October 4, 2008 - 2:35pm
tags:
York Pharma Plc Announces The Acquisition Of Leading Dermatological & Wound Care Brands
PR Inside
Saturday, October 4, 2008 - 2:34pm
tags:
Oscient Pharmaceuticals Receives NASDAQ Notice
Marketwatch
Saturday, October 4, 2008 - 2:32pm
tags:
Eli Lilly licenses potential cancer treatments from Deciphera Pharmaceuticals
Yahoo/AP
Friday, October 3, 2008 - 10:35am
tags:
Why All the ImClone Interest? Its Pipeline
Businessweek
Friday, October 3, 2008 - 9:58am
tags:
FDA Rejects Ban On Cough & Cold Medicines for Kids
WSJ Online
Friday, October 3, 2008 - 9:57am
tags:
Schering-Plough cut at Merrill, Vytorin/Zetia concerns cited
Marketwatch
Friday, October 3, 2008 - 9:55am
tags:
[video]TheStreet.com BioTalk: LLY, IMCL, AMLN, BMY
The Street.com
Friday, October 3, 2008 - 9:47am
tags:
Opko acquires rights to anti-inflammatory drug
Bizjournals.com
Friday, October 3, 2008 - 9:43am
tags:
Schering-Plough’s Hassan On Growth and Hard Times in Global Markets
WSJ Online
Friday, October 3, 2008 - 9:42am
tags:
Glaxo Pays $40 Million in (Another) Paxil Settlement
WSJ Online
Friday, October 3, 2008 - 9:37am
tags:
Bristol Deal Still Makes More Sense
Yahoo/Zacks.com
Friday, October 3, 2008 - 9:36am
tags:
Lawmakers probe Medtronic's consulting arrangements with docs, citing alleged kickbacks
Yahoo/AP
Friday, October 3, 2008 - 9:36am
tags:
Daiichi Sankyo Gets India's Approval to Buy Ranbaxy
Bloomberg
Friday, October 3, 2008 - 9:35am
tags:
Genentech, Roche in cancer treatment collaboration
Bizjournals.com
Friday, October 3, 2008 - 9:28am
tags:
Genentech reports psoriasis patient taking Raptiva developed a rare, deadly brain disease
Yahoo/AP
Friday, October 3, 2008 - 9:27am
tags:
Court upholds Amgen's anemia drug patents, affirms sales injunction need in Roche dispute
Yahoo/AP
Friday, October 3, 2008 - 9:26am
tags:
Exelixis says it has filed new drug application for cancer treatment candidate XL888
Yahoo/AP
Friday, October 3, 2008 - 9:25am
tags:

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.